Home Bright The Insurance Policy You Are Probably Overpaying Forand the One You Are Missing

The Insurance Policy You Are Probably Overpaying Forand the One You Are Missing

Share
the-insurance-policy-you-are-probably-overpaying-forand-the-one-you-are-missing
The Insurance Policy You Are Probably Overpaying Forand the One You Are Missing
Share

The biggest insurance mistakes can quietly cost you thousands of dollars. Nichcha/ShutterstockI paid $2,400 a year for a whole life insurance policy for six years before I realized it was one of the worst financial decisions I had ever made. A financial advisor—who earned a hefty commission on the sale—had convinced me that whole life insurance was an “investment” that would build cash value while protecting my family. What he did not explain was that the returns on the cash value were less than two percent, the fees were enormous, and I could get the same death benefit from a term policy for one-tenth the cost.When I canceled the whole life policy and switched to a 20-year term policy, my annual premium dropped from $2,400 to $280. I redirected the $2,120 difference into index fund investments that have grown at an average of eight percent annually. In the five years since the switch, that redirected money has grown to about $13,200—money that would have been trapped in a low-return insurance product with surrender charges.

Share
Related Articles
usda-unveils-new-support-for-ranchers-to-rebuild-cattle-herds
BusinessEconomyUSUS News

USDA Unveils New Support for Ranchers to Rebuild Cattle Herds

The U.S. Department of Agriculture has unveiled a new package of measures...

how-major-us-stock-indexes-fared-aug.-31
BrightBusinessInvestingMarketsPersonal FinanceStocks

How Major US Stock Indexes Fared Aug. 31

Oil prices rose and U.S. stocks fell after American forces struck Iranian...

trump-unveils-new-drug-pricing-deals-with-9-pharmaceutical-companies
BusinessCompaniesExecutive BranchUSUS NewsUS Politics

Trump Unveils New Drug Pricing Deals With 9 Pharmaceutical Companies

President Donald Trump on Aug. 31 announced agreements with nine midsize pharmaceutical...